Mammogram screening to detect breast cancer.
getty
Health and Human Services Secretary, Robert F. Kennedy Jr., is revamping the United States Preventive Services Task Force. He recently labeled the group as “lackadaisical” and dismissed its top leaders two weeks ago. This decision follows a pattern of meeting cancellations and unfilled roles over the past year. Concerns have been raised by public health experts about the potential negative consequences of such changes on health insurers’ coverage of preventive screenings. This is crucial because the task force provides evidence-based preventive care recommendations, which are required to be covered by insurers without patient cost-sharing under the Affordable Care Act. According to KFF, this ACA provision might affect more Americans than any other.
Since 1984, the USPSTF has been offering guidance on insurance coverage for preventive services and prescription drugs. Its members are unpaid specialists in prevention and evidence-based medicine, serving four-year terms without conflicts of interest. These members, including independent doctors, nurses, and public health experts, voluntarily assess scientific research on diseases like cardiovascular conditions, cancer, and HIV.
The task force reviews preventive healthcare services and technologies, issuing and updating recommendations across various treatments. These include cancer screenings such as mammograms and colonoscopies, HIV prevention medications, weight management counseling, alcohol and drug use counseling, prenatal testing, and statins for heart health.
Recommendations for medications or procedures are graded by the task force with letters (A, B, C, or D) based on the evidence’s strength and the preventive service’s benefits and harms. Health insurance must cover those with an A or B grade in both public and private sectors.
Kennedy recently removed two vice chairs from the panel, stating it was essential to bring in individuals aligned with a “clear mission.” The specifics of this mission remain unclear, but it could be linked to what the Wall Street Journal reported last year when they noted Kennedy thought the task force was “too woke,” referencing their efforts to tackle “systematic racism” and health disparities.
Initial signs of Kennedy’s intention to shake up the advisory panel appeared when he suddenly called off a meeting last summer. That meeting was set to discuss diet, physical activity, and weight loss as preventive measures for cardiovascular disease in adults. Despite these topics aligning with his Make America Healthy Again initiative aimed at chronic disease prevention, Kennedy canceled it without explanation.
The dismissal of key leaders on the panel has sparked concerns that the entire group might undergo changes similar to the Advisory Committee on Immunization Practices, which Kennedy overhauled in June by replacing its 17 members with hand-picked individuals, many sharing vaccine-skeptic views. The ACIP advises the CDC on vaccine recommendations, which health insurers consider in their coverage decisions.
The formation of a new panel remains uncertain. It is possible that Kennedy will replace the entire panel, as he did with ACIP.
Before the removal of the two vice chairs in May, previous task force leaders had already expressed concern over the task force’s future in light of Kennedy’s actions. They are particularly worried about the 42-year-old task force’s ability to retain its independence and integrity if a new, more politicized panel is appointed.
The upheaval has disrupted the panel’s daily operations. They had been working on draft guidelines for alcohol screening, cervical cancer self-swabs, perinatal depression, and vitamin D supplementation. The future of these guidelines is uncertain. More critically, these disruptions could change which preventive care services and technologies insurers cover.
Insurers might adjust their coverage rules, potentially eliminating previously covered services. However, they might continue to cover certain items if deemed medically necessary or beneficial to enrollees. Different priorities among insurers could lead to variations in coverage decisions, undermining the ACA provision’s goal of universal preventive care access.
